Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 2Thoracic 1Sarcoma 1NET 1Head & Neck 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 96Head and Neck Neoplasms 73Carcinoma, Non-Small-Cell Lung 34Thyroid Neoplasms 29Melanoma 26Ovarian Neoplasms 25Mouth Neoplasms 23Colorectal Neoplasms 20Oropharyngeal Neoplasms 19Breast Neoplasms 18Uterine Cervical Neoplasms 16Carcinoma, Squamous Cell 16Nasopharyngeal Carcinoma 15Lung Neoplasms 15Carcinoma, Renal Cell 15Neoplasm Metastasis 14Urinary Bladder Neoplasms 13Stomach Neoplasms 13Sarcoma 13Laryngeal Neoplasms 13Triple Negative Breast Neoplasms 12Prostatic Neoplasms 12Carcinoma 12Esophageal Neoplasms 11Endometrial Neoplasms 11Neoplasms 10Pancreatic Neoplasms 9Hypopharyngeal Neoplasms 9Salivary Gland Neoplasms 8Carcinoma, Transitional Cell 7

Interventions

repotrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endocrine System Diseases × Head & Neck × 30 days × Clear all
NCT03093116 2026-05-27

TRIDENT-1

Turning Point Therapeutics, Inc.

Phase 1/2 Recruiting
500 enrolled 2 FDA
EndocrineGastrointestinalHead & NeckNETSarcomaThoracic

Adenocarcinoma, Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Colonic Diseases, Colonic Neoplasms, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Sarcoma, Thoracic Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Neuroectodermal Tumors, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡